InVivoMAb Anti-Mouse IL6R (15A7)

Introducing InVivoMAb Anti-Mouse IL6R (15A7) – The Ideal Solution for Targeting IL6R in Biotech Research

InVivoMAb Anti-Mouse IL6R (15A7) is a highly specific and potent monoclonal antibody that targets the interleukin-6 receptor (IL6R) in mice. This innovative biotech product is designed to aid researchers in their quest to better understand the role of IL6R in various biological processes and diseases.

Biological Function:
IL6R is a transmembrane protein that plays a crucial role in the immune response and inflammation. It is a receptor for interleukin-6 (IL-6), a pro-inflammatory cytokine that is involved in a wide range of physiological and pathological processes. By binding to IL6R, IL-6 can activate signaling pathways that promote cell growth, differentiation, and survival. Dysregulation of IL6R has been linked to various diseases, including autoimmune disorders, cancer, and cardiovascular diseases.

Main Applications:
InVivoMAb Anti-Mouse IL6R (15A7) is a valuable tool for researchers studying the function of IL6R in different biological contexts. It can be used in a variety of applications, including:

1. In vitro studies – The antibody can be used to detect and quantify IL6R expression in cell lines and primary cells.

2. In vivo experiments – InVivoMAb Anti-Mouse IL6R (15A7) can be used in animal models to investigate the role of IL6R in various diseases and to evaluate the efficacy of potential therapeutics targeting IL6R.

3. Flow cytometry – The antibody can be used for flow cytometry analysis to identify and isolate cells expressing IL6R.

Experimental Use Cases:
InVivoMAb Anti-Mouse IL6R (15A7) has been successfully used in numerous research studies, demonstrating its reliability and effectiveness. Some notable examples include:

1. Investigating the role of IL6R in autoimmune diseases – In a recent study, researchers used InVivoMAb Anti-Mouse IL6R (15A7) to block IL6R signaling in a mouse model of rheumatoid arthritis. The results showed a significant decrease in disease severity, highlighting the potential of targeting IL6R in autoimmune diseases.

2. Studying the effect of IL6R inhibition on cancer progression – In another study, InVivoMAb Anti-Mouse IL6R (15A7) was used to block IL6R signaling in a mouse model of lung cancer. The findings revealed a significant decrease in tumor growth and metastasis, suggesting that targeting IL6R could be a promising therapeutic approach for cancer treatment.

3. Evaluating the efficacy of IL6R-targeting therapies – InVivoMAb Anti-Mouse IL6R (15A7) has also been used in pre-clinical studies to evaluate the efficacy of IL6R-targeting therapeutics, such as monoclonal antibodies and small molecule inhibitors.

With its high specificity and potency, InVivoMAb Anti-Mouse IL6R (15A7) is a valuable tool for researchers studying the role of IL6R in various biological processes and diseases. Its proven effectiveness in multiple experimental use cases makes it a top choice for biotech research targeting IL6R. Order now and take your research to the next level!